Reviewed by Peptide Treatments Medical Advisory Board
Tesamorelin: Bloodwork Guide
Recommended lab tests and biomarkers to monitor before, during, and after Tesamorelin therapy. Testing schedules are based on clinical protocols and published monitoring guidelines.
Back to Tesamorelin overviewDuring Treatment (3 tests)
| Biomarker | Expected Effect | Retest |
|---|---|---|
| IGF-1 | ↑ increases | Every 8 weeks |
| Visceral Fat | ↓ decreases | Every 12 weeks |
| Triglycerides | ↓ decreases | Every 12 weeks |